Kymera Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference
September 14, 2020 07:00 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics...
Kymera Therapeutics Appoints Biopharma Veterans Pamela Esposito and Jeff Albers to its Board of Directors
September 09, 2020 07:00 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics...
Kymera Therapeutics Appoints Dr. Richard Chesworth as Chief Scientific Officer
August 27, 2020 07:00 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that...
Kymera Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
August 25, 2020 16:01 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that...
Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering
August 20, 2020 20:36 ET
|
Kymera Therapeutics, Inc.
WATERTOWN, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that...